Projects per year
Personal profile
External positions
Assistant Professor of Clinical Medicine, Weill Cornell Medical College
Jan 1 2020 → …
Research Area Keywords
- Cancer
- Digestive Disorders
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
A PHASE 1, OPEN-LABEL, MULTICENTER STUDY OF JANX007 IN SUBJECTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
Heyne, K. (Key Personnel), Miles, B. J. (Key Personnel), Satkunasivam, R. (Key Personnel), Singh, M. (Key Personnel) & Zhang, J. (Key Personnel)
10/17/24 → …
Project: Clinical Trial
-
IMPACT ON SURVIVAL OF FAITH-BASED SPIRITUAL CARE OR PSYCHOTHERAPY COMBINED WITH PALLIATIVE CARE VERSUS PALLIATIVE CARE ALONE IN PATIENTS WITH NON-CURATIVE MALIGNANCIES
Mai, H. P. (PI), Abdelrahim, M. (Key Personnel), Chang, J. C. (Key Personnel), Ganguly, S. (Key Personnel), Heyne, K. (Key Personnel), Mathur, S. (Key Personnel), Niravath, P. A. (Key Personnel), Pingali, S. R. (Key Personnel), Shah, S. (Key Personnel), Sun, K. (Key Personnel), Venta, L. A. (Key Personnel) & Zhang, J. (Key Personnel)
6/19/24 → …
Project: Clinical Trial
-
Fulvestrant Plus Abemaciclib With or Without Run-In of Fulvestrant in Er-Positive, Her2-Negative Metastatic Breast Cancer
Chang, J. C. (PI), Heyne, K. (Key Personnel), Mai, H. P. (Key Personnel), Mathur, S. (Key Personnel), Niravath, P. A. (Key Personnel) & Sun, K. (Key Personnel)
7/15/21 → …
Project: Clinical Trial
-
Sample and Data Collection for Houston Methodist Cancer Center Research
Chang, J. C. (PI), Bernicker, E. H. (Key Personnel), Darcourt, J. (Key Personnel), Heyne, K. (Key Personnel), Niravath, P. A. (Key Personnel) & Singh, M. (Key Personnel)
4/9/20 → …
Project: Clinical Trial
-
CTSU - IRB SUBMISSIONA Phase III Trial To Evaluate The Efficacy Of The Addition Of Inotuzumab Ozogamicin (A Conjugated Anti-Cd22 Monoclonal Antibody) To Frontline Therapy In Young Adults (Ages 18-39 Years) With Newly Diagnosed Precursor B-Cell ALL.
Abdelrahim, M. (CoI), Bernicker, E. H. (CoI), Chang, J. C. (CoI), Heyne, K. (CoI), Niravath, P. A. (CoI), Singh, M. (CoI) & Zhang, J. (CoI)
3/6/20 → 3/5/45
Project: Non Profit
-
Outcomes of patients with unresectable hepatocellular carcinoma who developed an infection while receiving atezolizumab: P-409 - Abstract Book of the ESMO 25th World Congress on Gastrointestinal Cancer 2023, Barcelona, Spain, 28 June - 1 July 2023
Esmail, A., Xu, J., Burns, E., Gee, K., Wiechmann, C., Zhang, Y., Kieser, R., Gong, Z., Umoru, G., Shah, S., Sun, K., Heyne, K. & Abdelrahim, M., Jun 28 2023, In: Annals of Oncology. 34, 51, p. S156Research output: Contribution to journal › Conference article
-
Transplant Oncology: An Emerging Discipline of Cancer Treatment
Abdelrahim, M., Esmail, A., Abudayyeh, A., Murakami, N., Victor, D., Kodali, S., Cheah, Y. L., Simon, C. J., Noureddin, M., Connor, A., Saharia, A., Moore, L. W., Heyne, K., Kaseb, A. O., Gaber, A. O. & Ghobrial, R. M., Nov 9 2023, In: Cancers. 15, 22, p. 5337 1 p., 5337.Research output: Contribution to journal › Review article › peer-review
Open Access7 Scopus citations -
Trial in Progress: Neoadjuvant Combination Therapy of Lenvatinib Plus Transcatheter Arterial Chemoembolization (TACE) for Transplant-eligible Patients with Large HCC: Abstracts of the 15th Biennial Congress of the European-African Hepato-Pancreato-Biliary Association (E-AHPBA), 6-9 June 2023, Lyon, France.
Abdelrahim, M., Esmail, A., Saharia, A., Kodali, S., Victor, D., Heyne, K. & Ghobrial, R. M., 2023, In: HPB. 25, p. S560Research output: Contribution to journal › Article › peer-review
-
480 Impact of infections in patients with advanced or metastatic non-small cell lung cancer (NSCLC) receiving pembrolizumab-based therapies
Burns, E. A., Xu, J., Kieser, R., Muhsen, I., Shah, S., Umoru, G., Mylavarapu, C., Zhang, Y., Crenshaw, A., Sun, K., Esmail, A., Guerrero, C., Gong, Z., Gee, K., Heyne, K., Singh, M., Zhang, J., Bernicker, E. & Abdelrahim, M., Nov 1 2022, In: J Immunother Cancer. 10, Suppl 2, p. A501Research output: Contribution to journal › Article › peer-review
-
Combination of transarterial chemoembolization (TACE) and tyrosine kinase inhibitors (TKIs) compared to TACE alone as bridging therapy transplant recipients with hepatocellular carcinoma: An update. Journal of Clinical Oncology
Esmail, A., Victor, D., Kodali, S., Graviss, E. A., Nguyen, D. T., Moore, L. W., Saharia, A., McMillan, R., Fong, J. N., Uosef, A., Elshawwaf, M., Heyne, K., Ghobrial, R. M. & Abdelrahim, M., 2022, In: Journal of Clinical Oncology. 40, 16_suppl, p. e16201-e16201Research output: Contribution to journal › Article › peer-review